Status:
COMPLETED
Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis
Lead Sponsor:
University of Pecs
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18-90 years
Brief Summary
Aim: Determination of frequency and nature of coronary involvement (including epicardial and microvascular) among scleroderma patients referred for right heart catheterization.
Detailed Description
Systemic sclerosis (SSc)is a multiorgan autoimmune disease characterized by fibrosis of the skin and internal organs. Cardio-pulmonary manifestation in systemic sclerosis (SSc) patients has significan...
Eligibility Criteria
Inclusion
- patients with rheumatologist established systemic sclerosis
- informed consent
Exclusion
- left ventricular ejection fraction \<30%
- severly (\<60% of predicted) deteriorated pulmonary function
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00843102
Start Date
December 1 2007
End Date
May 1 2012
Last Update
June 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pécs, Hungary
Pécs, Hungary, H-7623